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A STUDY ON DYSLIPIDEMIA ASSOSCIATED WITH CHRONIC KIDNEY DISEASE AND THE ATHEROGENIC 
INDEX OF PLASMA IN VARIOUS STAGES OF CKD 
ABSTRACT 
INTRODUCTION : 
Chronic kidney disease (CKD) is associated with high risk for cardiovascular disease (CVD). This 
association is multifactorial, but CKD is often associated with dyslipidemia, which likely contributes. 
Patients with CKD have dyslipidemia even at early stages of renal dysfunction and dyslipidemia tends to 
progress with deterioration of kidney function. 
OBJECTIVES : 
To study the pattern of dyslipidemia in various stages of CKD and to assess the cardiovascular risk by 
correlating the atherogenic index of plasma to various stages of CKD 
METHODS : 
85 patients were carefully selected after assessing their eligibility using the inclusion and exclusion 
criteria. History, clinical examination and biochemical investigations were performed .Blood for the 
assessment of lipid profile was collected after a minimum of 8 hours fasting and a light fat free diet on 
the previous day. Data was analysed using SPSS software. 
RESULTS : 
 Patients with chronic kidney disease were likelier to have higher levels of triglyceride, VLDL - C and 
lower HDL values and as the stage of CKD progressed, the abnormalities in TGL and HDL values 
increased. There is no significant difference in the lipid levels between the diabetic and non - diabetic 
CKD population. Dialysis patients had a worsened lipid abnormality when compared with the pre dialysis 
patients.Atherogenic index of plasma was calculated, which showed a significant negative correlation 
with the stages of CKD. 
CONCLUSION : 
Lipid metabolism is significantly altered in most patients with renal failure. Our results indicate that CKD 
patients show significant abnormalities of lipid metabolism such as hyper - triglyceridemia, hyper – 
cholesterolemia and low HDL – C which contribute to atherosclerosis and cardiovascular diseases. 
Further research is needed to confirm whether early detection and treatment could be helpful in the 
prevention of adverse clinical outcomes in CKD patients. 
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